Zabihi Ebrahim, Hoseinzaadeh Aateffeh, Emami Maryam, Mardani Mahdieh, Mahmoud Baradaran, Akbar Moghadamnia Ali
Department of Pharmacology and Physiology, Babol University of Medical Sciences, Babol, Iran.
Subst Abuse. 2011;5:11-5. doi: 10.4137/SART.S6174. Epub 2011 Mar 14.
It has been almost three decades since tramadol was introduced to the market as a centrally acting analgesic. It is claimed to have weak opioid properties and a low dependence potential in opioid-addicted patients. This study was designed to investigate the suspicion of potential tramadol abuse among patients visiting pharmacies in Babol, one of the major cities in northern Iran.
Under supervision by pharmacists, a questionnaire designed to monitor drug abuse was filled out for every patient who requested tramadol from Babol's pharmacies during 6 months (Aug. 2007 till Feb. 2008). The data obtained were used to derive descriptive statistics and to make a comparison with results from other countries.
Of 162 patients (or someone on their behalf) who had sought tramadol from a pharmacy, 92 (56%) patients did not have a prescription. At least 103 (64%) patients reported criteria for addiction (ie, for feeling of psychological well being, unable to cease taking the drug, more than two weeks of tramadol use). In total, 145 (89%) patients were aged younger than 30 years, and 90 (55%) patients were aged younger than 18 years. More than 63% of patients reported a history of addiction or drug abuse. Most of the patients with no prescription (88%) had abuse/addiction criteria.
Patients who request tramadol from pharmacies in Babol seem to have a high potential for drug abuse, in particular those who do not have prescriptions. The high prevalence of people under 18 years of age seeking tramadol could be a worldwide trend. We recommend further governmental support for pharmacies to deal with tramadol abusers in northern Iran.
曲马多作为一种中枢性镇痛药被引入市场已近三十年。据称,它在阿片类药物成瘾患者中具有较弱的阿片类特性和较低的成瘾潜力。本研究旨在调查伊朗北部主要城市之一巴博尔的药房就诊患者中曲马多潜在滥用的嫌疑情况。
在药剂师的监督下,为2007年8月至2008年2月期间从巴博尔药房索取曲马多的每位患者填写一份旨在监测药物滥用的问卷。所获得的数据用于进行描述性统计,并与其他国家的结果进行比较。
在162名(或代表他们的人)从药房索取曲马多的患者中,92名(56%)患者没有处方。至少103名(64%)患者报告有成瘾标准(即,为了获得心理幸福感、无法停止用药、使用曲马多超过两周)。总共有145名(89%)患者年龄小于30岁,90名(55%)患者年龄小于18岁。超过63%的患者报告有药物成瘾或滥用史。大多数无处方的患者(88%)有成瘾/滥用标准。
从巴博尔药房索取曲马多的患者似乎有很高的药物滥用可能性,特别是那些没有处方的患者。18岁以下人群索取曲马多的高比例可能是一种全球趋势。我们建议政府进一步支持药房应对伊朗北部的曲马多滥用者。